Executive Management
August Troendle, MD
Chief Executive Officer & Chairman of the Board of Directors
Dr. Troendle has been the Chief Executive Officer and Chairman of the Board of Directors of Medpace since he founded the company in July 1992. Before founding Medpace, Dr. Troendle served as a manager from 1987 to 1992 at Sandoz (Novartis), where he was responsible for the clinical development of lipid altering agents. From 1986 to 1987, Dr. Troendle worked as a Medical Review Officer in the Division of Metabolic and Endocrine Drug Products at the FDA.
Dr. Troendle also has extensive experience serving as a director for a diverse group of public and private companies, including as a director of Coherus BioSciences, Inc. from 2012 to February 2018, as a director of Xenon Pharmaceuticals Inc. from 2007 to 2008, as a director of LIB Therapeutics, LLC since 2015, as a director of CinCor Pharma, Inc. from March 2018 to November 2021, and as a director of CinRx Pharma, LLC since 2015. Dr. Troendle received his Medical Degree from the University of Maryland, School of Medicine and his Master of Business Administration from Boston University.
Jesse Geiger
President
Jesse J. Geiger joined Medpace in October 2007 as Corporate Controller, and he was appointed Chief Financial Officer in March 2011. Mr. Geiger became Chief Operating Officer, Laboratory Operations in November 2014. Mr. Geiger was appointed to the position of President on August 1, 2021. Prior to joining Medpace, Mr. Geiger worked for SENCORP from 2004 to 2007 as the Corporate Controller and Manager of Financial Planning and Analysis.
Prior to SENCORP, Mr. Geiger served as the Director of Capital Markets for Cincinnati Bell from 2002 to 2004. Mr. Geiger started his career in the audit practice at Arthur Andersen LLP. Mr. Geiger has served as a director for several private companies, including as a director of LIB Therapeutics, LLC since 2015 and as a director of CinRx Pharma, LLC since 2015. Mr. Geiger received his Bachelor of Business Administration in Accounting from the University of Cincinnati and is a Certified Public Accountant (Inactive).
Senior Leadership – CRO
Susan Burwig, MA, BSN
Executive Vice President,
Operations
Joined Medpace in 1993
Weimin Gai, MS
Senior Vice President,
Biometrics
Joined Medpace in 1993
Reinilde Heyrman, MD
Chief Medical Officer,
Medical Department
Joined Medpace in 2017
Gina Leisring, MPH
Senior Vice President,
Clinical Monitoring
Joined Medpace in 2002
Traci Turner, MD
Vice President,
MRL Operations and MARC
Joined Medpace in 2011
Brad Hansman
Vice President,
Site Activation & Maintenance
Joined Medpace in 2011
Corporate
Kevin Brady
Chief Financial Officer
Joined Medpace in 2018
Amy Gasser Callow, JD
Vice President, Human Resources and Assistant General Counsel
Joined Medpace in 2016
Brandon Ebken
Chief Information Officer
Joined Medpace in 2021
Stephen Ewald, JD
General Counsel, Chief Compliance Officer and Corporate Secretary
Joined Medpace in 2012
Jennifer Ruth
Vice President, Quality Assurance and Process Improvement
Joined Medpace in 2006
Todd Meyers
Vice President, Business Development and Marketing
Joined Medpace in 2013
John T. Wynne, MBA
Senior Vice President, Commercial Operations and Phase I Unit
Joined Medpace 2003